Publication:
Thymoquinone and Sorafenib as a therapeutic combination in liver cancer: In vitro and in vivo.

dc.contributor.authorGÜLER, ERAY METİN
dc.contributor.authorKOÇYİĞİT, ABDÜRRAHİM
dc.contributor.institutionauthorGÜLER, ERAY METİN
dc.contributor.institutionauthorKOÇYİĞİT, ABDÜRRAHİM
dc.date.accessioned2020-03-28T20:59:10Z
dc.date.available2020-03-28T20:59:10Z
dc.date.issued2019-10-31T00:00:00Z
dc.identifier.citationGÜLER E. M. , KOÇYİĞİT A., -Thymoquinone and Sorafenib as a therapeutic combination in liver cancer: In vitro and in vivo.-, 27th Balkan Clinical Laboratory Federation (BCLF) and the 30th National TBS Congress, Antalya, Türkiye, 27 - 31 Ekim 2019
dc.identifier.urihttps://hdl.handle.net/20.500.12645/16132
dc.identifier.yoksis6176781
dc.language.isoen
dc.titleThymoquinone and Sorafenib as a therapeutic combination in liver cancer: In vitro and in vivo.
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.id02f69140-cd5e-40ae-86ea-7ff270c33bf4
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication68927a51-77a5-4d08-8370-23b470160061
relation.isAuthorOfPublication75babbd2-f46b-4121-aa00-54d883a6f907
relation.isAuthorOfPublication.latestForDiscovery68927a51-77a5-4d08-8370-23b470160061
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files